199 related articles for article (PubMed ID: 30059513)
1. Hepatitis B virus reactivation after radiotherapy for hepatocellular carcinoma and efficacy of antiviral treatment: A multicenter study.
Jun BG; Kim YD; Kim SG; Kim YS; Jeong SW; Jang JY; Lee SH; Kim HS; Kang SH; Kim MY; Baik SK; Lee M; Kim TS; Choi DH; Choi SH; Suk KT; Kim DJ; Cheon GJ
PLoS One; 2018; 13(7):e0201316. PubMed ID: 30059513
[TBL] [Abstract][Full Text] [Related]
2. Effects of transarterial chemoembolization combined with antiviral therapy on HBV reactivation and liver function in HBV-related hepatocellular carcinoma patients with HBV-DNA negative.
Wang K; Jiang G; Jia Z; Zhu X; Ni C
Medicine (Baltimore); 2018 Jun; 97(22):e10940. PubMed ID: 29851833
[TBL] [Abstract][Full Text] [Related]
3. Effects of TACE and preventive antiviral therapy on HBV reactivation and subsequent hepatitis in hepatocellular carcinoma: a meta-analysis.
Zhang SS; Liu JX; Zhu J; Xiao MB; Lu CH; Ni RZ; Qu LS
Jpn J Clin Oncol; 2019 Jul; 49(7):646-655. PubMed ID: 30968933
[TBL] [Abstract][Full Text] [Related]
4. Effects of antiviral therapy on hepatitis B virus reactivation and liver function after resection or chemoembolization for hepatocellular carcinoma.
Lao XM; Luo G; Ye LT; Luo C; Shi M; Wang D; Guo R; Chen M; Li S; Lin X; Yuan Y
Liver Int; 2013 Apr; 33(4):595-604. PubMed ID: 23402625
[TBL] [Abstract][Full Text] [Related]
5. Reactivation of hepatitis B virus in HBsAg-negative patients with hepatocellular carcinoma.
Jang JW; Kim YW; Lee SW; Kwon JH; Nam SW; Bae SH; Choi JY; Yoon SK; Chung KW
PLoS One; 2015; 10(3):e0122041. PubMed ID: 25894607
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Prophylactic Entecavir for Hepatitis B Virus-Related Hepatocellular Carcinoma Receiving Transcatheter Arterial Chemoembolization.
Li X; Zhong X; Chen ZH; Wang TT; Ma XK; Xing YF; Wu DH; Dong M; Chen J; Ruan DY; Lin ZX; Wen JY; Wei L; Wu XY; Lin Q
Asian Pac J Cancer Prev; 2015; 16(18):8665-70. PubMed ID: 26745134
[TBL] [Abstract][Full Text] [Related]
7. Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma.
Huang L; Li J; Lau WY; Yan J; Zhou F; Liu C; Zhang X; Shen J; Wu M; Yan Y
J Gastroenterol Hepatol; 2012 Jan; 27(1):158-64. PubMed ID: 21871026
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis B virus reactivation after three-dimensional conformal radiotherapy in patients with hepatitis B virus-related hepatocellular carcinoma.
Kim JH; Park JW; Kim TH; Koh DW; Lee WJ; Kim CM
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):813-9. PubMed ID: 17524569
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus reactivation after radiofrequency ablation or hepatic resection for HBV-related small hepatocellular carcinoma: a retrospective study.
Dan JQ; Zhang YJ; Huang JT; Chen MS; Gao HJ; Peng ZW; Xu L; Lau WY
Eur J Surg Oncol; 2013 Aug; 39(8):865-72. PubMed ID: 23597497
[TBL] [Abstract][Full Text] [Related]
10. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels.
Huang G; Lai EC; Lau WY; Zhou WP; Shen F; Pan ZY; Fu SY; Wu MC
Ann Surg; 2013 Mar; 257(3):490-505. PubMed ID: 22868358
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus reactivation in hepatocellular carcinoma patients undergoing transcatheter arterial chemoembolization therapy.
Peng JW; Lin GN; Xiao JJ; Jiang XM
Asia Pac J Clin Oncol; 2012 Dec; 8(4):356-61. PubMed ID: 22897940
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B reactivation after treatment for HBV-related hepatocellular carcinoma: comparative analysis of radiofrequency ablation versus hepatic resection].
Liu F; Dan J; Zhang Y; Chen M; Huang J; Xie R
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):38-42. PubMed ID: 24721242
[TBL] [Abstract][Full Text] [Related]
13. Risk of hepatitis B exacerbation is low after transcatheter arterial chemoembolization therapy for patients with HBV-related hepatocellular carcinoma: report of a prospective study.
Park JW; Park KW; Cho SH; Park HS; Lee WJ; Lee DH; Kim CM
Am J Gastroenterol; 2005 Oct; 100(10):2194-200. PubMed ID: 16181368
[TBL] [Abstract][Full Text] [Related]
14. Risk of HBV reactivation according to viral status and treatment intensity in patients with hepatocellular carcinoma.
Jang JW; Kwon JH; You CR; Kim JD; Woo HY; Bae SH; Choi JY; Yoon SK; Chung KW
Antivir Ther; 2011; 16(7):969-77. PubMed ID: 22024512
[TBL] [Abstract][Full Text] [Related]
15. Comparison of HBV reactivation between patients with high HBV-DNA and low HBV-DNA loads undergoing PD-1 inhibitor and concurrent antiviral prophylaxis.
He MK; Peng C; Zhao Y; Liang RB; Lai ZC; Kan A; Li QJ; Wei W; Zhang YJ; Chen MS; Guo RP; Shi M
Cancer Immunol Immunother; 2021 Nov; 70(11):3207-3216. PubMed ID: 33813646
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for hepatitis B virus reactivation after conformal radiotherapy in patients with hepatocellular carcinoma.
Huang W; Zhang W; Fan M; Lu Y; Zhang J; Li H; Li B
Cancer Sci; 2014 Jun; 105(6):697-703. PubMed ID: 24654677
[TBL] [Abstract][Full Text] [Related]
17. The progress and prospects of routine prophylactic antiviral treatment in hepatitis B-related hepatocellular carcinoma.
Jiang E; Shangguan AJ; Chen S; Tang L; Zhao S; Yu Z
Cancer Lett; 2016 Sep; 379(2):262-7. PubMed ID: 26272181
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiviral therapy on post-hepatectomy HBV reactivation and liver function in HBV DNA-negative patients with HBV-related hepatocellular carcinoma.
Gong WF; Zhong JH; Lu SD; Wang XB; Zhang QM; Ma L; Zhang ZM; Xiang BD; Li LQ
Oncotarget; 2017 Feb; 8(9):15047-15056. PubMed ID: 28122361
[TBL] [Abstract][Full Text] [Related]
19. Changes of HBV DNA After Chemoembolization for Hepatocellular Carcinoma and the Efficacy of Antiviral Treatment.
Lin XJ; Lao XM; Shi M; Li SP
Dig Dis Sci; 2016 Sep; 61(9):2465-76. PubMed ID: 27105647
[TBL] [Abstract][Full Text] [Related]
20. Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization.
Yoo SH; Jang JW; Kwon JH; Jung SM; Jang B; Choi JY
Clin Mol Hepatol; 2016 Dec; 22(4):458-465. PubMed ID: 28081589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]